VaccineLedger
Driving Transparency in Public Health Logistics
VaccineLedger is Statwig's flagship digital platform that transforms immunization supply chains by providing complete end-to-end visibility from procurement to last-mile delivery. Built for public health systems, it brings together all key stakeholders- government agencies, suppliers, cold chain operators, healthcare workers-on a single platform.
With a smart and secure mobile and web application, VaccineLedger ensures every dose is tracked, verified, and accounted for, in real time. From warehouse to health facility to beneficiary, VaccineLedger builds trust, minimizes waste, and supports data-driven decision-making.
With a smart and secure mobile and web application, VaccineLedger ensures every dose is tracked, verified, and accounted for, in real time. From warehouse to health facility to beneficiary, VaccineLedger builds trust, minimizes waste, and supports data-driven decision-making.
Platform Features
Stock Control
Monitor inventory levels across locations in real time with alerts for low stock, overstock, and expiring products.
Prevent Wastage
Implement FEFO (First Expiry First Out) and batch tracking to minimize product losses and maximize shelf life efficiency.
Track Shipments in Real Time
Geolocation and live tracking ensure complete transparency from dispatch to delivery with digital proof of receipt.
Gen Al for Smart Conversations and Reporting
Engage with the system via Al-powered chatbot for generating reports, checking stock, forecasting, and placing orders using natural language.
Demand Forecasting
Predict vaccine and supply needs using historical consumption, usage patterns, and seasonal trends to reduce shortages.
Last Mile Delivery and Visibility
Ensure equitable access by tracking doses down to the last mile and mapping deliveries directly to the beneficiaries.
Platform Features
01
Stock Control
Monitor inventory levels across locations in real time with alerts for low stock, overstock, and expiring products.
02
Prevent Wastage
Implement FEFO (First Expiry First Out) and batch tracking to minimize product losses and maximize shelf life efficiency.
03
Track Shipments in Real Time
Geolocation and live tracking ensure complete transparency from dispatch to delivery with digital proof of receipt.
04
Gen Al for Smart Conversations and Reporting
Engage with the system via Al-powered chatbot for generating reports, checking stock, forecasting, and placing orders using natural language.
05
Demand Forecasting
Predict vaccine and supply needs using historical consumption, usage patterns, and seasonal trends to reduce shortages.
06
Last Mile Delivery and Visibility
Ensure equitable access by tracking doses down to the last mile and mapping deliveries directly to the beneficiaries.
Impact Created So Far
Countries Deployed
0
Registered Users
0
Transactions Recorded
0
+
Products Tracked
million+ doses
Products Tracked
0
million+ doses
Wastage Prevented
0
%
Beneficiaries Reached
0
+
Awards & Recognition
Our work in public health and supply chain transparency has been recognized globally for its innovation, impact, and dedication to equitable health outcomes.
UNICEF Innovation Fund Portfolio Company
Statwig is proud to be part of the UNICEF Innovation Fund, supporting breakthrough solutions to strengthen public health infrastructure in low- and middle-income countries (LMICs).
Digital Public Good (DPG) Recognized by the United Nations
VaccineLedger has been officially recognized as a Digital Public Good by the UN Secretary General for its open-source, scalable, and inclusive design, meeting the highest standards of transparency and accessibility.
Featured in Forbes Top 50 Blockchain Solutions
Forbes named VaccineLedger among the top 50 blockchain solutions globally creating real-world impact-highlighting its use in improving vaccine access and reducing supply chain inefficiencies.
Winner of The Trinity Challenge
VaccineLedger won the prestigious Trinity Challenge for its innovative approach to transforming pharmaceutical supply chains and enabling rapid, data-driven responses to future pandemics.